INVIVO THERAPEUTICS HOLDINGS CORP. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Invivo Therapeutics Holdings Corp. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2023.
  • Invivo Therapeutics Holdings Corp. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$2.7M, a 2.11% increase year-over-year.
  • Invivo Therapeutics Holdings Corp. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2023 was -$9.33M, a 15.5% increase year-over-year.
  • Invivo Therapeutics Holdings Corp. annual Net Income (Loss) Attributable to Parent for 2022 was -$10.5M, a 6.01% decline from 2021.
  • Invivo Therapeutics Holdings Corp. annual Net Income (Loss) Attributable to Parent for 2021 was -$9.9M, a 9.05% decline from 2020.
  • Invivo Therapeutics Holdings Corp. annual Net Income (Loss) Attributable to Parent for 2020 was -$9.07M, a 23.3% increase from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$9.33M -$2.7M +$58K +2.11% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$9.39M -$1.94M +$782K +28.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-08
Q1 2023 -$10.2M -$2.33M +$323K +12.2% Jan 1, 2023 Mar 31, 2023 10-Q 2023-11-08
Q4 2022 -$10.5M -$2.36M +$551K +18.9% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-01
Q3 2022 -$11M -$2.76M -$304K -12.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$10.7M -$2.72M -$410K -17.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-08
Q1 2022 -$10.3M -$2.66M -$432K -19.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-08
Q4 2021 -$9.9M -$2.91M -$720K -32.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-01
Q3 2021 -$9.18M -$2.45M -$172K -7.55% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$9M -$2.31M -$120K -5.48% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-07
Q1 2021 -$8.88M -$2.22M +$191K +7.91% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-07
Q4 2020 -$9.07M -$2.19M +$1.18M +35% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-07
Q3 2020 -$10.3M -$2.28M +$400K +14.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$10.7M -$2.19M +$955K +30.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 -$11.6M -$2.41M +$221K +8.39% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$11.8M -$3.37M -$847K -33.5% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 -$11M -$2.68M +$496K +15.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$11.5M -$3.14M +$9.8M +75.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 -$21.3M -$2.64M +$2.15M +44.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 -$23.4M -$2.53M +$2.14M +45.9% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-20
Q3 2018 -$25.6M -$3.18M +$6.18M +66% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$31.7M -$12.9M -$6.6M -104% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 -$25.1M -$4.78M +$1.61M +25.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$26.7M -$4.66M +$771K +14.2% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 -$27.5M -$9.35M -$3.15M -50.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$24.4M -$6.34M -$1.16M -22.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$23.2M -$6.39M +$232K +3.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-07
Q4 2016 -$23.4M -$5.44M -$702K -14.8% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-12
Q3 2016 -$22.7M -$6.2M -$3.89M -168% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-30
Q2 2016 -$18.8M -$5.18M +$5.26M +50.4% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 -$24.1M -$6.62M +$9.21M +58.2% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-06
Q4 2015 -$33.3M -$4.73M +$3.65M +43.5% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-12
Q3 2015 -$37M -$2.31M -$1.1M -90.3% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-04
Q2 2015 -$35.9M -$10.4M -$6.8M -186% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 -$29.1M -$15.8M -$10.7M -210% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 -$18.3M -$8.38M -$2.68M -46.9% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-04
Q3 2014 -$15.7M -$1.21M +$4.22M +77.7% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 -$19.9M -$3.65M +$10.6M +74.5% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 -$30.5M -$5.1M +$8.22M +61.7% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 -$38.8M -$5.71M +$3.01M +34.5% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-04
Q3 2013 -$41.8M -$5.44M -$13.5M -168% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-05
Q2 2013 -$28.3M -$14.3M -$16.5M -749% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-06
Q1 2013 -$11.8M -$13.3M -$16.5M -523% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $4.66M -$8.72M +$26.4M +75.2% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-11
Q3 2012 -$21.8M $8.03M +$4.96M +162% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 -$26.7M $2.2M +$3.57M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-07
Q1 2012 -$30.3M $3.15M +$4.43M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 -$34.7M -$35.1M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-17
Q3 2011 $3.07M +$3.9M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 -$1.37M -$400K -41.2% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-13
Q1 2011 -$1.28M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-14
Q3 2010 -$837K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$970K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.